Exchange: NASDAQ·Updated 07:52 PM EDT
MIST logo

MIST Milestone Pharmaceuticals Inc

$1.20
$0.01
(0.83%)
Today
Closed $1.20
$0.01
(0.83%)
After Hours
Reported EarningsAug 12
Mkt Cap$149.4M
Vol1.59M

About MIST

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines to benefit people living with certain heart conditions. Milestone’s lead product is CARDAMYST® (etripamil) nasal spray, a novel calcium channel blocker, which is FDA-approved for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. Etripamil is also in Phase 3 development for the control of symptomatic episodic attacks associated with AFib-RVR. https://milestonepharma.com/
56

Bullish Sentiment

How do you feel about MIST?

Advertisement|Remove ads.